ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Grassley, House Republicans Launch Investigations Of I-ELCAP Conflicts.

June 6, 2008

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

October 4, 1996

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

NCAB Votes Down Dietary Fat Study In women; Proposal highly Recommended By Study Section

September 29, 1989

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012

CCOP Application Now Total 180 Plus

November 26, 1982